Faron results don’t entice investors
Biopharmaceutical firm Faron tumbled 2.94% after posting an operating loss of €6.3 million for the half-year ended 30th June.
6 years ago
Latest
Recovery on the cards for the Henderson Opportunities Trust
Micro-cap funds like Henderson Opportunities Trust could bounce back strongly in the event that a no-deal Brexit is avoided, writes…
6 years ago
Bellway: a cheap stock with long-term growth potential
Robert Stephens discusses why the FTSE 250 housebuilder could offer a more robust financial outlook than its current valuation suggests.
6 years ago
Evil Knievil: I need some help here
Simon Cawkwell, AKA Evil Knievil, with his latest trading and gambling exploits – writing exclusively for Master Investor.
6 years ago
Investec caught out by tough market conditions
Shares in Investec dropped by 6.70% after it said that challenging market conditions meant that its first-half revenues would below…
6 years ago
Norish results chill market sentiment
AIM-listed firm Norish saw its share price drop by 4.76% despite a 43% improvement in pre-tax profits for the six…
6 years ago
Venture Life moves higher after half-year update
Shares in AIM-listed care products firm Venture Life Group climbed 1.92% after revenues for the six months to 30th June…
6 years ago
Small cap round up: featuring StatPro, Cohort, Helical and more…
In this weekly summary, Mark Watson-Mitchell updates his readers on previous company profiles and other news of interest from the…
6 years ago
When Jeremy met Bernie… the nightmare of the ‘utopian’ future
It is February 2021 and Comrade Jeremy, First Citizen of the Socialist Republic of Britain, is visiting US President Bernie…
6 years ago
Clinigen rises on revenue performance
Shares in AIM-listed pharmaceuticals firm Clinigen climbed by 5.21% after its revenues for the year ended 30th June jumped 20%.
6 years ago